FDA Inspection 896663 — Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc. — FEI 3006031727

The FDA completed an inspection of Alexion Pharmaceuticals, Inc. on September 26, 2014 in New Haven, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 26, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Haven, CT (United States)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report
683221 CFR 314.80(c)(2)Late submission of annual safety reports